| Title | Cancer Management and Research |
| Abbreviation | Cancer Manag. Res. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Oncology (Q2) |
| h-index | 58 |
| Overall Rank/Ranking | 6466 |
| SCImago Journal Rank (SJR) | 0.754 |
| Impact Score | 3.25 |
| Publisher | Dove Medical Press Ltd. |
| Country | New Zealand |
| ISSN | 11791322 |
| Best Quartile | Q2 |
| Coverage History | 2010-2022 |
Cancer Management and Research is a journal covering the technologies/fields/categories related to Oncology (Q2). It is published by Dove Medical Press Ltd.. The overall rank of Cancer Management and Research is 6466. According to SCImago Journal Rank (SJR), this journal is ranked 0.754. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 58. The best quartile for this journal is Q2.
The ISSN of Cancer Management and Research journal is 11791322. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cancer Management and Research is cited by a total of 10376 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Cancer Management and Research is 3.25, which is computed in 2023 as per its definition. Cancer Management and Research IF is decreased by a factor of 0.19 and approximate percentage change is -5.52% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Cancer Management and Research is 3.25. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.25 |
| 2021 | 3.44 |
| 2020 | 3.61 |
| 2019 | 2.89 |
| 2018 | 2.32 |
| 2017 | 3.98 |
| 2016 | 4.68 |
| 2015 | 4.73 |
| 2014 | 3.89 |
Cancer Management and Research has an h-index of 58. It means 58 articles of this journal have more than 58 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Cancer Management and Research is 11791322. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Cancer Management and Research is 6466. According to SCImago Journal Rank (SJR), this journal is ranked 0.754. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.754 |
| 2021 | 0.729 |
| 2020 | 1.024 |
| 2019 | 0.797 |
| 2018 | 0.892 |
| 2017 | 1.519 |
| 2016 | 1.455 |
| 2015 | 1.386 |
| 2014 | 1.224 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 6466 |
| 2021 | 6501 |
| 2020 | 4238 |
| 2019 | 5945 |
| 2018 | 5100 |
| 2017 | 2246 |
| 2016 | 2495 |
| 2015 | 2723 |
| 2014 | 3227 |
Cancer Management and Research is published by Dove Medical Press Ltd.. It's publishing house is located in New Zealand. Coverage history of this journal is as following: 2010-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Cancer Management and Research is Cancer Manag. Res.. This abbreviation ('Cancer Manag. Res.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Oncology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Cancer Management and Research latest impact IF is 3.25. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 4.73 (2015) and 2.32 (2018), respectively, in the last 9 years. Moreover, its average IS is 3.64 in the previous 9 years.
The Cancer Management and Research has an SJR (SCImago Journal Rank) of 0.754, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.519 in 2017 and the lowest being 0.729 in 2021. Furthermore, the average SJR of the Cancer Management and Research over the previous 9-year period stands at 3.64.
The latest h-index of the Cancer Management and Research is 58.
The Cancer Management and Research is published by the Dove Medical Press Ltd., with its country of publication being the New Zealand.
The Cancer Management and Research is currently ranked 6466 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 2246 in 2017 and its lowest position of 6501 in 2021.
The standard ISO4 abbreviation for the Cancer Management and Research is Cancer Manag. Res..
Cancer Management and Research is classified as a journal that the Dove Medical Press Ltd. publishes.
The Cancer Management and Research encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Cancer Management and Research is assigned the following International Standard Serial Numbers (ISSN): 11791322.
The best quartile for the Cancer Management and Research is Q2 (2022).
The Cancer Management and Research coverage history can be summarized as follows: 2010-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division | conference and proceedings | 17477 | 16 | 0.00 | |
| Proceedings of the International Symposium on Power Semiconductor Devices and ICs | conference and proceedings | 7015 | 49 | 2.14 | |
| Journal of Geriatric Physical Therapy | journal | 5578 | Lippincott Williams and Wilkins Ltd. | 43 | 1.80 |
| World Englishes | journal | 4960 | Wiley-Blackwell | 60 | 1.97 |
| Educational Measurement: Issues and Practice | journal | 4494 | Wiley-Blackwell Publishing Ltd | 59 | 1.53 |
| Journal of Immigrant and Refugee Studies | journal | 9246 | Routledge | 32 | 1.46 |
| Journal of Sociology | journal | 6009 | SAGE Publications Ltd | 58 | 3.21 |
| European Journal of Cancer, Supplement | journal | 9063 | Elsevier Ltd. | 28 | 1.93 |
| Expert Review of Clinical Pharmacology | journal | 5241 | Taylor and Francis Ltd. | 53 | 4.10 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.25 |
| 2021 | 3.44 |
| 2020 | 3.61 |
| 2019 | 2.89 |
| 2018 | 2.32 |
| 2017 | 3.98 |
| 2016 | 4.68 |
| 2015 | 4.73 |
| 2014 | 3.89 |
